The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition

Samudra K. Dissanayake, Michael Wade, Carrie E. Johnson, Michael P. O'Connell, Poloko D. Leotlela, Amanda D. French, Kavita V. Shah, Kyle J Hewitt, Devin T. Rosenthal, Fred E. Indig, Yuan Jiang, Brian J. Nickoloff, Dennis D. Taub, Jeffrey M. Trent, Randall T. Moon, Michael Bittner, Ashani T. Weeraratna

Research output: Contribution to journalArticle

247 Citations (Scopus)

Abstract

We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) versus loss-of-function (siRNA knockdown) of WNT5A by microarray analysis. Increasing WNT5A suppressed the expression of several genes, which were re-expressed after small interference RNA-mediated knockdown of WNT5A. Genes affected by WNT5A include KISS-1, a metastasis suppressor, and CD44, involved in tumor cell homing during metastasis. This could be validated at the protein level using both small interference RNA and recombinant Wnt5A (rWnt5A). Among the genes up-regulated by WNT5A was the gene vimentin, associated with an epithelial to mesenchymal transition (EMT), which involves decreases in E-cadherin, due to up-regulation of the transcriptional repressor, Snail. rWnt5A treatment increases Snail and vimentin expression, and decreases E-cadherin, even in the presence of dominant-negative TCF4, suggesting that this activation is independent of Wnt/β-catenin signaling. Because Wnt5A can signal via protein kinase C (PKC), the role of PKC in Wnt5A-mediated motility and EMT was also assessed using PKC inhibition and activation studies. Treating cells expressing low levels of Wnt5A with phorbol ester increased Snail expression inhibiting PKC in cells expressing high levels of Wnt5A decreased Snail. Furthermore, inhibition of PKC before Wnt5A treatment blocked Snail expression, implying that Wnt5A can potentiate melanoma metastasis via the induction of EMT in a PKC-dependent manner.

Original languageEnglish (US)
Pages (from-to)17259-17271
Number of pages13
JournalJournal of Biological Chemistry
Volume282
Issue number23
DOIs
StatePublished - Jun 8 2007

Fingerprint

Epithelial-Mesenchymal Transition
Protein Kinase C
Melanoma
Neoplasm Metastasis
Genes
Cells
Snails
Vimentin
Cadherins
RNA Interference
Chemical activation
Catenins
Phorbol Esters
Microarray Analysis
Microarrays
Small Interfering RNA
Cell Movement
Wnt-5a Protein
Tumors
Up-Regulation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. / Dissanayake, Samudra K.; Wade, Michael; Johnson, Carrie E.; O'Connell, Michael P.; Leotlela, Poloko D.; French, Amanda D.; Shah, Kavita V.; Hewitt, Kyle J; Rosenthal, Devin T.; Indig, Fred E.; Jiang, Yuan; Nickoloff, Brian J.; Taub, Dennis D.; Trent, Jeffrey M.; Moon, Randall T.; Bittner, Michael; Weeraratna, Ashani T.

In: Journal of Biological Chemistry, Vol. 282, No. 23, 08.06.2007, p. 17259-17271.

Research output: Contribution to journalArticle

Dissanayake, SK, Wade, M, Johnson, CE, O'Connell, MP, Leotlela, PD, French, AD, Shah, KV, Hewitt, KJ, Rosenthal, DT, Indig, FE, Jiang, Y, Nickoloff, BJ, Taub, DD, Trent, JM, Moon, RT, Bittner, M & Weeraratna, AT 2007, 'The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition', Journal of Biological Chemistry, vol. 282, no. 23, pp. 17259-17271. https://doi.org/10.1074/jbc.M700075200
Dissanayake, Samudra K. ; Wade, Michael ; Johnson, Carrie E. ; O'Connell, Michael P. ; Leotlela, Poloko D. ; French, Amanda D. ; Shah, Kavita V. ; Hewitt, Kyle J ; Rosenthal, Devin T. ; Indig, Fred E. ; Jiang, Yuan ; Nickoloff, Brian J. ; Taub, Dennis D. ; Trent, Jeffrey M. ; Moon, Randall T. ; Bittner, Michael ; Weeraratna, Ashani T. / The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 23. pp. 17259-17271.
@article{c6bcfeb25e0e44c3b4597dffc8400d93,
title = "The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition",
abstract = "We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) versus loss-of-function (siRNA knockdown) of WNT5A by microarray analysis. Increasing WNT5A suppressed the expression of several genes, which were re-expressed after small interference RNA-mediated knockdown of WNT5A. Genes affected by WNT5A include KISS-1, a metastasis suppressor, and CD44, involved in tumor cell homing during metastasis. This could be validated at the protein level using both small interference RNA and recombinant Wnt5A (rWnt5A). Among the genes up-regulated by WNT5A was the gene vimentin, associated with an epithelial to mesenchymal transition (EMT), which involves decreases in E-cadherin, due to up-regulation of the transcriptional repressor, Snail. rWnt5A treatment increases Snail and vimentin expression, and decreases E-cadherin, even in the presence of dominant-negative TCF4, suggesting that this activation is independent of Wnt/β-catenin signaling. Because Wnt5A can signal via protein kinase C (PKC), the role of PKC in Wnt5A-mediated motility and EMT was also assessed using PKC inhibition and activation studies. Treating cells expressing low levels of Wnt5A with phorbol ester increased Snail expression inhibiting PKC in cells expressing high levels of Wnt5A decreased Snail. Furthermore, inhibition of PKC before Wnt5A treatment blocked Snail expression, implying that Wnt5A can potentiate melanoma metastasis via the induction of EMT in a PKC-dependent manner.",
author = "Dissanayake, {Samudra K.} and Michael Wade and Johnson, {Carrie E.} and O'Connell, {Michael P.} and Leotlela, {Poloko D.} and French, {Amanda D.} and Shah, {Kavita V.} and Hewitt, {Kyle J} and Rosenthal, {Devin T.} and Indig, {Fred E.} and Yuan Jiang and Nickoloff, {Brian J.} and Taub, {Dennis D.} and Trent, {Jeffrey M.} and Moon, {Randall T.} and Michael Bittner and Weeraratna, {Ashani T.}",
year = "2007",
month = "6",
day = "8",
doi = "10.1074/jbc.M700075200",
language = "English (US)",
volume = "282",
pages = "17259--17271",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "23",

}

TY - JOUR

T1 - The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition

AU - Dissanayake, Samudra K.

AU - Wade, Michael

AU - Johnson, Carrie E.

AU - O'Connell, Michael P.

AU - Leotlela, Poloko D.

AU - French, Amanda D.

AU - Shah, Kavita V.

AU - Hewitt, Kyle J

AU - Rosenthal, Devin T.

AU - Indig, Fred E.

AU - Jiang, Yuan

AU - Nickoloff, Brian J.

AU - Taub, Dennis D.

AU - Trent, Jeffrey M.

AU - Moon, Randall T.

AU - Bittner, Michael

AU - Weeraratna, Ashani T.

PY - 2007/6/8

Y1 - 2007/6/8

N2 - We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) versus loss-of-function (siRNA knockdown) of WNT5A by microarray analysis. Increasing WNT5A suppressed the expression of several genes, which were re-expressed after small interference RNA-mediated knockdown of WNT5A. Genes affected by WNT5A include KISS-1, a metastasis suppressor, and CD44, involved in tumor cell homing during metastasis. This could be validated at the protein level using both small interference RNA and recombinant Wnt5A (rWnt5A). Among the genes up-regulated by WNT5A was the gene vimentin, associated with an epithelial to mesenchymal transition (EMT), which involves decreases in E-cadherin, due to up-regulation of the transcriptional repressor, Snail. rWnt5A treatment increases Snail and vimentin expression, and decreases E-cadherin, even in the presence of dominant-negative TCF4, suggesting that this activation is independent of Wnt/β-catenin signaling. Because Wnt5A can signal via protein kinase C (PKC), the role of PKC in Wnt5A-mediated motility and EMT was also assessed using PKC inhibition and activation studies. Treating cells expressing low levels of Wnt5A with phorbol ester increased Snail expression inhibiting PKC in cells expressing high levels of Wnt5A decreased Snail. Furthermore, inhibition of PKC before Wnt5A treatment blocked Snail expression, implying that Wnt5A can potentiate melanoma metastasis via the induction of EMT in a PKC-dependent manner.

AB - We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) versus loss-of-function (siRNA knockdown) of WNT5A by microarray analysis. Increasing WNT5A suppressed the expression of several genes, which were re-expressed after small interference RNA-mediated knockdown of WNT5A. Genes affected by WNT5A include KISS-1, a metastasis suppressor, and CD44, involved in tumor cell homing during metastasis. This could be validated at the protein level using both small interference RNA and recombinant Wnt5A (rWnt5A). Among the genes up-regulated by WNT5A was the gene vimentin, associated with an epithelial to mesenchymal transition (EMT), which involves decreases in E-cadherin, due to up-regulation of the transcriptional repressor, Snail. rWnt5A treatment increases Snail and vimentin expression, and decreases E-cadherin, even in the presence of dominant-negative TCF4, suggesting that this activation is independent of Wnt/β-catenin signaling. Because Wnt5A can signal via protein kinase C (PKC), the role of PKC in Wnt5A-mediated motility and EMT was also assessed using PKC inhibition and activation studies. Treating cells expressing low levels of Wnt5A with phorbol ester increased Snail expression inhibiting PKC in cells expressing high levels of Wnt5A decreased Snail. Furthermore, inhibition of PKC before Wnt5A treatment blocked Snail expression, implying that Wnt5A can potentiate melanoma metastasis via the induction of EMT in a PKC-dependent manner.

UR - http://www.scopus.com/inward/record.url?scp=34447131518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447131518&partnerID=8YFLogxK

U2 - 10.1074/jbc.M700075200

DO - 10.1074/jbc.M700075200

M3 - Article

VL - 282

SP - 17259

EP - 17271

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 23

ER -